Vitamin C and Sepsis: Is Bayesian Reanalysis Useful to Translate the Results of Frequentist Randomized Trials?
- PMID: 37439646
- DOI: 10.1097/CCM.0000000000005939
Vitamin C and Sepsis: Is Bayesian Reanalysis Useful to Translate the Results of Frequentist Randomized Trials?
Conflict of interest statement
The authors have disclosed that they do not have any potential conflicts of interest.
Comment on
-
IV Vitamin C in Adults With Sepsis: A Bayesian Reanalysis of a Randomized Controlled Trial.Crit Care Med. 2023 Aug 1;51(8):e152-e156. doi: 10.1097/CCM.0000000000005871. Epub 2023 Apr 7. Crit Care Med. 2023. PMID: 37026849 Clinical Trial.
References
-
- Angriman F, Muttalib F, Lamontagne F, et al.; LOVIT Investigators: IV Vitamin C in Adults With Sepsis: A Bayesian Reanalysis of a Randomized Controlled Trial. Crit Care Med. 2023; 51:e152–e156
-
- Lamontagne F, Masse MH, Menard J, et al.; LOVIT Investigators and the Canadian Critical Care Trials Group: Intravenous vitamin C in adults with sepsis in the intensive care unit. N Engl J Med. 2022; 386:2387–2398
-
- Kalil AC: Lack of benefit of high-dose vitamin C, thiamine, and hydrocortisone combination for patients with sepsis. JAMA. 2020; 323:419–420
-
- Kalil AC, Sun J: Bayesian methodology for the design and interpretation of clinical trials in critical care medicine: A primer for clinicians. Crit Care Med. 2014; 42:2267–2277
-
- Yarnell CJ, Abrams D, Baldwin MR, et al.: Clinical trials in critical care: Can a Bayesian approach enhance clinical and scientific decision making? Lancet Respir Med. 2021; 9:207–216
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical